Owens & Minor price target lowered to $18 from $21 at Baird

Baird lowered the firm’s price target on Owens & Minor to $18 from $21 and keeps a Neutral rating on the shares. The firm noted the Street is cautious over medical volumes, GLP-1 impacts in both segments particularly Patient Direct, PPE destocking, leverage, and more.